| scholarly article | Q13442814 |
| P2093 | author name string | C C Chao | |
| H O McDevitt | |||
| R Ettinger | |||
| M Vadeboncoeur | |||
| S H Munson | |||
| J Toma | |||
| P2860 | cites work | The role of tumor necrosis factor and lymphotoxin in lymphoid organ development | Q73089999 |
| LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator | Q24308657 | ||
| A newly identified member of the tumor necrosis factor receptor superfamily with a wide tissue distribution and involvement in lymphocyte activation | Q28238947 | ||
| Effects of tumor necrosis factor and lymphotoxin on peripheral lymphoid tissue development | Q28277546 | ||
| Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family | Q28295196 | ||
| Distinct roles in lymphoid organogenesis for lymphotoxins alpha and beta revealed in lymphotoxin beta-deficient mice | Q28587819 | ||
| Vascular addressins are induced on islet vessels during insulitis in nonobese diabetic mice and are involved in lymphoid cell binding to islet endothelium | Q33908874 | ||
| Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes | Q36367942 | ||
| Disrupted splenic architecture, but normal lymph node development in mice expressing a soluble lymphotoxin-beta receptor-IgG1 fusion protein. | Q36688075 | ||
| The ligands and receptors of the lymphotoxin system | Q40541150 | ||
| IgG effector mechanisms. | Q41339539 | ||
| Surface lymphotoxin alpha/beta complex is required for the development of peripheral lymphoid organs | Q42196937 | ||
| Involvement of beta 7 integrin and mucosal addressin cell adhesion molecule-1 (MAdCAM-1) in the development of diabetes in obese diabetic mice. | Q46036349 | ||
| The lymphotoxin beta receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues | Q47713235 | ||
| Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. | Q55066037 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1333-1340 | |
| P577 | publication date | 2001-06-01 | |
| P1433 | published in | Journal of Experimental Medicine | Q3186912 |
| P1476 | title | A critical role for lymphotoxin-beta receptor in the development of diabetes in nonobese diabetic mice | |
| P478 | volume | 193 |
| Q58787844 | A DNA-Methylated Sight on Autoimmune Inflammation Network across RA, pSS, and SLE |
| Q40440208 | A Lymphotoxin/Type I IFN Axis Programs CD8+ T Cells To Infiltrate a Self-Tissue and Propagate Immunopathology |
| Q53295110 | A Role for Lymphotoxin in Primary Sjögren’s Disease |
| Q35679191 | A role for surface lymphotoxin in experimental autoimmune encephalomyelitis independent of LIGHT. |
| Q39824927 | Administration of dendritic cells dual expressing DcR3 and GAD65 mediates the suppression of T cells and induces long-term acceptance of pancreatic-islet transplantation |
| Q37207114 | Blockade of lymphotoxin-beta receptor signaling reduces aspects of Sjögren's syndrome in salivary glands of non-obese diabetic mice |
| Q35136409 | CCR7 directs the recruitment of T cells into inflamed pancreatic islets of nonobese diabetic (NOD) mice |
| Q37299504 | CXCL13 blockade disrupts B lymphocyte organization in tertiary lymphoid structures without altering B cell receptor bias or preventing diabetes in nonobese diabetic mice |
| Q34006517 | Concerted action of wild-type and mutant TNF receptors enhances inflammation in TNF receptor 1-associated periodic fever syndrome |
| Q38025388 | Control of dichotomic innate and adaptive immune responses by artery tertiary lymphoid organs in atherosclerosis. |
| Q28207830 | Endogenous association of TRAF2, TRAF3, cIAP1, and Smac with lymphotoxin beta receptor reveals a novel mechanism of apoptosis |
| Q33843700 | Germinal centre frequency is decreased in pancreatic lymph nodes from individuals with recent-onset type 1 diabetes |
| Q36818990 | LIGHT-related molecular network in the regulation of innate and adaptive immunity |
| Q37251618 | LIGHT/IFN-γ triggers β cells apoptosis via NF-κB/Bcl2-dependent mitochondrial pathway |
| Q35951798 | Lymphotoxin and LIGHT signaling pathways and target genes |
| Q33399367 | Lymphotoxin beta receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of aged ApoE-/- mice |
| Q40630236 | Lymphotoxin pathway directs thymic Aire expression |
| Q39245218 | Lymphotoxin signalling in tertiary lymphoid structures and immunotherapy. |
| Q35219029 | Lymphotoxin/light, lymphoid microenvironments and autoimmune disease |
| Q33869955 | Mouse aorta smooth muscle cells differentiate into lymphoid tissue organizer-like cells on combined tumor necrosis factor receptor-1/lymphotoxin beta-receptor NF-kappaB signaling |
| Q34731168 | Multiple roles for tumor necrosis factor-alpha and lymphotoxin alpha/beta in immunity and autoimmunity |
| Q73072574 | Secondary lymphoid organs are important but not absolutely required for allograft responses |
| Q30743828 | TNF ligands and receptors in autoimmunity: an update |
| Q27025082 | The Lymphotoxin Network: orchestrating a type I interferon response to optimize adaptive immunity |
| Q33986306 | The central role of antigen presentation in islets of Langerhans in autoimmune diabetes |
| Q24683018 | The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games |
| Q36604759 | The lymphotoxin pathway: beyond lymph node development. |
| Q35914953 | The role of LIGHT in T cell-mediated immunity. |
| Q37770209 | The unexpected role of lymphotoxin beta receptor signaling in carcinogenesis: from lymphoid tissue formation to liver and prostate cancer development |
| Q36399452 | Transgenic expression of decoy receptor 3 protects islets from spontaneous and chemical-induced autoimmune destruction in nonobese diabetic mice |
Search more.